Neurones Depreciation & Amortization Growth & History (NRO)
Neurones's depreciation and amortization was €19.6M for fiscal 2025.
View full Neurones company overviewNeurones annual depreciation and amortization history
2020
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €19.6M | €1.9M | +10.75% |
| 2024 | 2024-12-31 | €17.7M | €898,000 | +5.36% |
| 2023 | 2023-12-31 | €16.8M | €8.2M | +96.72% |
| 2022 | 2022-12-31 | €8.5M | €992,000 | +13.18% |
| 2021 | 2021-12-31 | €7.5M | −€1.0M | −12.03% |
| 2020 | 2020-12-31 | €8.6M | — | — |
Neurones depreciation and amortization trends
Over the last five fiscal years, Neurones's depreciation and amortization increased from €8.6M to €19.6M, a change of €11.0M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Neurones source filings ↗